The Journal of Immunology, Vol 154, Issue 11 5951-5958, Copyright © 1995 by American Association of Immunologists

ARTICLES

Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues

C Schonbach, M Ibe, H Shiga, Y Takamiya, K Miwa, K Nokihara and M Takiguchi
Department of Tumor Biology, University of Tokyo, Japan.

The prerequisites of peptide HLA-B*3501 interactions have been revisited by quantitative peptide binding assays with 190 chemically synthesized peptide possessing two anchor residues corresponding to the HLA-B*3501 peptide motif and a statistical residue-position analysis of binding and nonbinding peptides. According to the peptide motif of HLA- B*3501, aliphatic hydrophobic (Leu, Ile, and Met) or aromatic residues (Tyr and Phe) specify the main anchor at the C terminus, and position 2 renders an auxiliary anchor for proline. The importance of these residues was confirmed as a minimum requirement for peptide binding. Moreover, we demonstrated that high affinity peptide binding requires more than one favorable position of positions 3, 4, and 7. Aliphatic hydrophobic residues and residues that contain -OH or -SH side chains in position 3, 7, and 4 significantly enhance binding. Positions 1 and 5, or 7 may deteriorate peptide binding if these positions are held by proline and small residues (Ala and Gly) or basic residues carrying positively charged side chains (Arg and Lys), respectively. Positions 6 and 8 were statistically free of constrains. Yet, bulky aromatic residues and basic residues with a positively charged side chain at position 8 decreased the binding affinity. These findings were used to assess the predictability of binding and nonbinding peptides. Our binding predictions of 28 nonamers were verified by experimental data. Taking into account the importance of anchor and nonanchor positions in peptide binding and their practical value in peptide binding prediction, the search for peptide epitopes becomes more efficient.

This article has been cited by other articles:

				F. E. Tynan, N. A. Borg, J. J. Miles, T. Beddoe, D. El-Hassen, S. L. Silins, W. J. M. van Zuylen, A. W. Purcell, L. Kjer-Nielsen, J. McCluskey, et al. High Resolution Structures of Highly Bulged Viral Epitopes Bound to Major Histocompatibility Complex Class I: IMPLICATIONS FOR T-CELL RECEPTOR ENGAGEMENT AND T-CELL IMMUNODOMINANCE J. Biol. Chem., June 24, 2005; 280(25): 23900 - 23909. [Abstract] [Full Text] [PDF]

				H. Benlalam, B. Linard, Y. Guilloux, A. Moreau-Aubry, L. Derre, E. Diez, B. Dreno, F. Jotereau, and N. Labarriere Identification of Five New HLA-B*3501-Restricted Epitopes Derived from Common Melanoma-Associated Antigens, Spontaneously Recognized by Tumor-Infiltrating Lymphocytes J. Immunol., December 1, 2003; 171(11): 6283 - 6289. [Abstract] [Full Text] [PDF]

				K. Maenaka, T. Maenaka, H. Tomiyama, M. Takiguchi, D. I. Stuart, and E. Y. Jones Nonstandard Peptide Binding Revealed by Crystal Structures of HLA-B*5101 Complexed with HIV Immunodominant Epitopes J. Immunol., September 15, 2000; 165(6): 3260 - 3267. [Abstract] [Full Text] [PDF]

				D. Hudrisier, H. Mazarguil, F. Laval, M. B.A. Oldstone, and J. E. Gairin Binding of Viral Antigens to Major Histocompatibility Complex Class I H-2Db Molecules Is Controlled by Dominant Negative Elements at Peptide Non-anchor Residues. IMPLICATIONS FOR PEPTIDE SELECTION AND PRESENTATION J. Biol. Chem., July 26, 1996; 271(30): 17829 - 17836. [Abstract] [Full Text] [PDF]